IS2428B - Fljótandi lyfjasamsetning - Google Patents
Fljótandi lyfjasamsetningInfo
- Publication number
- IS2428B IS2428B IS6986A IS6986A IS2428B IS 2428 B IS2428 B IS 2428B IS 6986 A IS6986 A IS 6986A IS 6986 A IS6986 A IS 6986A IS 2428 B IS2428 B IS 2428B
- Authority
- IS
- Iceland
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- liquid
- composition
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29383201P | 2001-05-25 | 2001-05-25 | |
US34373301P | 2001-10-25 | 2001-10-25 | |
PCT/IB2002/001500 WO2002094220A1 (en) | 2001-05-25 | 2002-04-29 | Liquid pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
IS6986A IS6986A (is) | 2003-10-09 |
IS2428B true IS2428B (is) | 2008-10-15 |
Family
ID=26968180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS6986A IS2428B (is) | 2001-05-25 | 2003-10-09 | Fljótandi lyfjasamsetning |
Country Status (44)
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094757C (zh) | 1996-07-24 | 2002-11-27 | 沃尼尔·朗伯公司 | 用于治疗疼痛的异丁基γ-氨基丁酸及其衍生物 |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
EP1545491A1 (en) * | 2002-08-15 | 2005-06-29 | Pfizer Limited | Therapeutic use of fused bicyclic or tricyclic amino acids |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
WO2004054566A1 (en) * | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
ATE368456T1 (de) * | 2002-12-20 | 2007-08-15 | Dynogen Pharmaceuticals Inc | Behandlung nicht-schmerzhafter blasenstörungen mit modulatoren von alpha-2-delta- calciumkanaluntereinheiten |
US7169812B2 (en) * | 2003-07-01 | 2007-01-30 | Medtronic, Inc. | Process for producing injectable gabapentin compositions |
CN1849153A (zh) * | 2003-09-12 | 2006-10-18 | 辉瑞大药厂 | 含有α-2-δ配体和5-羟色胺/去甲肾上腺素重摄取抑制剂的组合物 |
ES2373042T3 (es) * | 2003-10-08 | 2012-01-30 | Mallinckrodt Llc | Solución de metilfenidato y procedimientos de administración y producción asociados. |
US20050090549A1 (en) * | 2003-10-23 | 2005-04-28 | Medtronic, Inc. | Intrathecal gabapentin for treatment of pain |
US20050090548A1 (en) * | 2003-10-23 | 2005-04-28 | Medtronic, Inc. | Intrathecal gabapentin for treatment of epilepsy |
EP1543831A1 (en) * | 2003-12-18 | 2005-06-22 | Pfizer GmbH Arzneimittelwerk Gödecke | Pregabalin composition |
DE102004015752B4 (de) * | 2004-03-31 | 2007-04-05 | Christian-Albrechts-Universität Zu Kiel | Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen |
CN101039664A (zh) * | 2004-10-14 | 2007-09-19 | 大金工业株式会社 | 气氛改变方法、用于该气氛改变方法的喷雾剂与喷雾装置 |
CA2618481A1 (en) * | 2005-08-11 | 2007-02-15 | Boehringer Ingelheim International Gmbh | Compounds for treating alzheimer's disease |
JP2009504613A (ja) * | 2005-08-11 | 2009-02-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アルツハイマー病の治療用化合物 |
DE102007019071A1 (de) * | 2007-04-23 | 2008-10-30 | Ratiopharm Gmbh | Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin |
JP2010043063A (ja) * | 2008-05-09 | 2010-02-25 | Agency For Science Technology & Research | 川崎病の診断及び治療 |
EP2246044A1 (en) * | 2009-04-21 | 2010-11-03 | Pierre Fabre Dermo-Cosmétique | Paediatric solutions comprising a beta-blocker |
HU230031B1 (hu) | 2010-03-01 | 2015-05-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény |
TR201005241A1 (tr) * | 2010-05-25 | 2012-01-23 | Sanovel �La� San. Ve T�C. A.�. | Kontrollü salım sağlayan pregabalin solüsyon formülasyonu. |
WO2015144825A1 (en) * | 2014-03-27 | 2015-10-01 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Oral liquid pharmaceutical solution of gabapentin |
CN104940930A (zh) * | 2015-05-31 | 2015-09-30 | 黑龙江佰彤儿童药物研究有限公司 | 一种治疗儿童癫痫药物口服乳剂及其制备方法 |
US11918684B2 (en) | 2017-03-13 | 2024-03-05 | Liqmeds Worldwide Limited | Pharmaceutical composition of oral suspension of immunosuppressive agents |
WO2019038584A1 (en) | 2017-08-19 | 2019-02-28 | Ftf Pharma Private Limited | ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PREPARATION METHOD THEREOF |
WO2019186515A1 (en) * | 2018-03-30 | 2019-10-03 | Ftf Pharma Private Limited | Liquid pharmaceutical compositions of antiepileptic drugs |
US20210308044A1 (en) | 2018-08-18 | 2021-10-07 | Ftf Pharma Private Limited | Pharmaceutical suspension for oral dosage |
US12083222B2 (en) | 2018-08-18 | 2024-09-10 | Oncosol Limited | Chemotherapeutic pharmaceutical suspension for oral dosage |
JP7500600B2 (ja) | 2019-03-26 | 2024-06-17 | オリオン コーポレーション | プレガバリン製剤およびその使用 |
JPWO2022168968A1 (is) * | 2021-02-05 | 2022-08-11 | ||
EP4395758A1 (en) * | 2021-08-31 | 2024-07-10 | Avion Pharmaceuticals, LLC | Stable gabapentin powder |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294520B1 (en) * | 1989-03-27 | 2001-09-25 | Albert T. Naito | Material for passage through the blood-brain barrier |
IL139298A0 (en) * | 1998-05-15 | 2001-11-25 | Warner Lambert Co | Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
DE60106968T2 (de) * | 2000-11-30 | 2005-11-03 | Pfizer Products Inc., Groton | Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren |
-
2002
- 2002-04-29 NZ NZ529173A patent/NZ529173A/en unknown
- 2002-04-29 ES ES02727834T patent/ES2265040T3/es not_active Expired - Lifetime
- 2002-04-29 EP EP02727834A patent/EP1395242B1/en not_active Expired - Lifetime
- 2002-04-29 DK DK02727834T patent/DK1395242T3/da active
- 2002-04-29 BR BR0209973-0A patent/BR0209973A/pt not_active IP Right Cessation
- 2002-04-29 RS YU87203A patent/RS87203A/sr unknown
- 2002-04-29 PT PT02727834T patent/PT1395242E/pt unknown
- 2002-04-29 HU HU0401366A patent/HUP0401366A2/hu unknown
- 2002-04-29 MX MXPA03009392A patent/MXPA03009392A/es active IP Right Grant
- 2002-04-29 AT AT02727834T patent/ATE334656T1/de not_active IP Right Cessation
- 2002-04-29 CN CNB028098080A patent/CN100346779C/zh not_active Expired - Fee Related
- 2002-04-29 GE GE5340A patent/GEP20053620B/en unknown
- 2002-04-29 EA EA200301152A patent/EA008087B1/ru not_active IP Right Cessation
- 2002-04-29 OA OA1200300296A patent/OA12604A/en unknown
- 2002-04-29 SK SK1411-2003A patent/SK286227B6/sk not_active IP Right Cessation
- 2002-04-29 WO PCT/IB2002/001500 patent/WO2002094220A1/en active IP Right Grant
- 2002-04-29 AP APAP/P/2003/002907A patent/AP1815A/en active
- 2002-04-29 SI SI200230371T patent/SI1395242T1/xx unknown
- 2002-04-29 DE DE60213592T patent/DE60213592T2/de not_active Expired - Fee Related
- 2002-04-29 KR KR1020037015326A patent/KR100582963B1/ko not_active IP Right Cessation
- 2002-04-29 EE EEP200300587A patent/EE200300587A/xx unknown
- 2002-04-29 CZ CZ20033066A patent/CZ299755B6/cs not_active IP Right Cessation
- 2002-04-29 CA CA002446574A patent/CA2446574C/en not_active Expired - Fee Related
- 2002-04-29 AU AU2002258026A patent/AU2002258026B2/en not_active Ceased
- 2002-04-29 PL PL02366384A patent/PL366384A1/xx not_active Application Discontinuation
- 2002-04-29 JP JP2002590939A patent/JP2004534764A/ja active Pending
- 2002-04-29 IL IL15835902A patent/IL158359A0/xx unknown
- 2002-05-21 MY MYPI20021869A patent/MY128615A/en unknown
- 2002-05-22 EG EG20020541A patent/EG24078A/xx active
- 2002-05-23 DO DO2002000403A patent/DOP2002000403A/es unknown
- 2002-05-23 PE PE2002000433A patent/PE20030087A1/es not_active Application Discontinuation
- 2002-05-23 AR ARP020101922A patent/AR033922A1/es unknown
- 2002-05-24 PA PA20028545901A patent/PA8545901A1/es unknown
- 2002-05-24 SV SV2002001053A patent/SV2003001053A/es not_active Application Discontinuation
- 2002-05-28 US US10/156,213 patent/US20020198261A1/en not_active Abandoned
-
2003
- 2003-06-24 US US10/602,215 patent/US7256216B2/en not_active Expired - Lifetime
- 2003-10-09 IS IS6986A patent/IS2428B/is unknown
- 2003-10-14 HR HR20030833A patent/HRP20030833B1/xx not_active IP Right Cessation
- 2003-10-28 ZA ZA2003/08393A patent/ZA200308393B/en unknown
- 2003-11-17 CR CR7150A patent/CR7150A/es not_active Application Discontinuation
- 2003-11-19 MA MA27406A patent/MA27026A1/fr unknown
- 2003-11-21 BG BG108376A patent/BG108376A/bg unknown
- 2003-11-24 NO NO20035200A patent/NO20035200D0/no not_active Application Discontinuation
-
2004
- 2004-07-28 HK HK04105579A patent/HK1062646A1/xx not_active IP Right Cessation
-
2006
- 2006-08-10 CY CY20061101125T patent/CY1105147T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1395242T3 (da) | Flydende farmaceutisk sammensætning | |
FI20011478A0 (fi) | Farmaseuttinen koostumus | |
NO20033384D0 (no) | Farmasöytisk formulering | |
DK1524266T3 (da) | Farmaceutisk sammensætning | |
NO20033785L (no) | Farmasöytisk formulering | |
ATE298634T1 (de) | Flüssigkeitszerstäuber | |
EE05020B1 (et) | Glburiidi ravimkoostis | |
IS7051A (is) | Lyfjasamsetningar | |
NO20035627D0 (no) | Farmasöytisk formulering | |
FI20022128A (fi) | Farmaseuttinen koostumus | |
DK1425005T3 (da) | Farmaceutisk sammensætning indeholdende lumiracoxib | |
ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
NO20041485L (no) | Farmasoytisk formulering omfattende (R)-bicalutamid | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
ATE350029T1 (de) | Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain | |
NO20015534D0 (no) | Farmasöytisk blandeapparat | |
NO20033073L (no) | Farmasöytisk sammensetning inneholdende citalopram | |
DE10107261B4 (de) | Pharmazeutische Zusammensetzung | |
FI20012242A0 (fi) | Uudet farmaseuttiset yhdisteet | |
FI5468U1 (fi) | Farmaseuttinen koostumus | |
NO20041236L (no) | Farmasoytisk formulering | |
SE0100847D0 (sv) | Novel pharmaceutical composition | |
SE0101325D0 (sv) | Pharmaceutical formulation | |
SE0101326D0 (sv) | Pharmaceutical formulation | |
SE0102957D0 (sv) | Pharmaceutical formulation |